Lipid lowering in acute coronary syndromes: New evidence, new questions Gregory G. SchwartzAnders G. Olsson Invited Commentary Pages: 1 - 3
Statins in homozygous familial hypercholesterolemia A. D. MaraisD. J. BlomJ. C. Firth OriginalPaper Pages: 19 - 25
Goals of statin therapy: Three viewpoints Gilbert R. ThompsonChristopher J. PackardNeil J. Stone ReviewPaper Pages: 26 - 33
A general assessment of the safety of HMG CoA reductase inhibitors (statins) Donald M. Black OriginalPaper Pages: 34 - 41
Statins and inflammatory markers Christopher C. CaseChristie M. Ballantyne OriginalPaper Pages: 42 - 47
Postmenopausal hormone replacement therapy as antiatherosclerotic therapy Howard N. HodisWendy J. MackRoger Lobo OriginalPaper Pages: 52 - 58
Peroxisome proliferator-activated receptors Ouliana ZiouzenkovaStephane PerreyJorge Plutzky OriginalPaper Pages: 59 - 64
Inhibition of acyl coenzyme a-cholesterol acyltransferase: A possible treatment of atherosclerosis? Therese M. Heinonen OriginalPaper Pages: 65 - 70